AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 253 min read$APOG

Apogee (APOG) To Report Earnings Tomorrow: Here Is What To Expect

Apogee (NASDAQ:APOG) will report earnings Friday before market open, according to the article. Last quarter, it posted revenue of $351.4 million, up 1.6% year over year, and beat analysts’ revenue and adjusted operating income estimates, with full-year revenue guidance above expectations. For this quarter, analysts expect revenue to fall 4.3% year over year.

Original reporting
finance.yahoo.com
Published Jun 25, 2026, 6:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 7:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Apogee (APOG) To Report Earnings Tomorrow: Here Is What To Expect — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$APOGNeutralMed
01

Why it matters

Traders can use the stated consensus revenue decline (4.3% YoY) and the pre-market timing to frame expectations for the earnings reaction and implied volatility into the print.

02

Market read

Provides the earnings calendar timing and the consensus revenue direction into the report, but does not disclose new guidance or results beyond prior-quarter context.

03

What to watch

The article lacks margin, backlog, and guidance specifics for this quarter; those items often dominate the post-earnings move more than the headline revenue YoY rate.

Relevance 5/10Novelty 4/10Timing: pre-market Friday earnings release

Background

The piece is a pre-earnings preview: it cites last quarter’s revenue beat and notes analysts have reconfirmed estimates over the last 30 days.

Company-level read

Ticker impact

$APOGNeutralMedium confidence
Context

Apogee is scheduled to report earnings Friday before market hours, with consensus expecting revenue down 4.3% YoY.

Expected impact

Moderate two-sided reaction likely, driven by revenue trajectory vs the 4.3% YoY decline expectation and any guidance commentary.

Evidence & confidence

The article provides timing (pre-market Friday) and the key consensus setup (4.3% YoY revenue decline) but no new guidance or fresh datapoint beyond prior-quarter context.

Market effects

Sector

As the first among its peers to report, Apogee’s print could set an early read-through for building-products earnings expectations.

Regional

No specific regional impact described.

Global

No explicit global macro linkage beyond general building-products sentiment.

Counterpoint

What could challenge this read

Recent strength (stock up 14%) may already price in a beat; if revenue still declines near 4% YoY, the stock could sell off despite a “rarely misses” history.

Key entities

  • company
    Apogee

    Architectural products company reporting earnings Friday before market hours.

Read at source← All news

Related articles

JUL 20
$APOGMedAI 8/10

Apogee to buy Luca Mariano Distillery for $19.5m

Apogee 21 (A21 Wine & Spirits) says it was selected as the successful bidder in a Chapter 11 court sale to buy Luca Mariano Distillery for $19.5m, including a 529-acre campus, assets, and about 6,600 ageing Bourbon barrels. The company plans to fund the purchase via $7m from investors, senior secured debt, and other financing, plus a $20m Series D. It also signed an LOI to buy Rod & Hammer’s whiskey brand and distillery in California.

thespiritsbusiness.com5 min
JUL 1
$APOGMed

APOGEE ENTERPRISES, INC. (APOG): Completion of Acquisition or Disposition of Assets

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. apog-20260701 0000006845 false 0000006845 2024-11-04 2024-11-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

SEC EDGAR 8-K2 min
JUN 27
$APOGMed

Apogee (APOG) Q1 2027 Earnings Call Transcript

Apogee’s Q1 FY2027 earnings call said net sales fell 1.1% to $343M as lower metals and glass volume was partly offset by pricing and mix. Adjusted EBITDA margin fell to 9.4% (from 9.9%); adjusted diluted EPS rose to $0.57. Backlog ended at $735M (+8% YoY). The company cited rising input costs, pricing actions, and softer glass conditions, and reiterated full-year guidance of $1.38B–$1.43B net sales and $2.70–$3.25 adjusted EPS. Apogee expects Kalwall acquisition revenue of ~$85M at ~15% adjusted

finance.yahoo.com6 min
JUN 26
$APOGMedAI 8/10

Why Is Apogee Enterprises Stock Soaring Friday? - Apogee Enterprises (NASDAQ:APOG)

Apogee Enterprises reported Q1 adjusted diluted EPS of 57 cents, above the 45-cent consensus, on net sales of $342.7 million versus $333.8 million expected. The company cited pricing/product mix for offsetting a 1.1% volume decline. Operating income rose to $18.8 million; operating margin to 5.5%. It kept fiscal 2027 adjusted EPS guidance of $2.70–$3.25 and sales outlook of $1.38–$1.43 billion; Kalwall acquisition remains on track for early July. Shares were up 9.44% to $46.49.

benzinga.com4 min
JUN 26
$APOGMed

APOGEE ENTERPRISES, INC. (APOG): Results of Operations and Financial Condition

APOGEE ENTERPRISES, INC. (APOG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a53026fy27q1results.htm EX-99.1 Document Press Release FOR RELEASE: June 26, 2026 APOGEE ENTERPRISES REPORTS FISCAL 2027 FIRST QUARTER RESULTS • First-quarter net sales of $342.7 million • First-quarter diluted EPS of $0.54 and adjusted diluted EPS of $0.57 • Pending Ka

SEC EDGAR 8-K4 min
JUN 22
$GOOGMed

Dow Jones still in the green but Nasdaq drops as hawkish Fed still looms

US stocks opened with the Dow up about 0.5% and the S&P 500 up just over 0.3%, while the Nasdaq was flat as investors took profits in tech. Alphabet fell 5.5% after losing AI researcher Noam Shazeer to OpenAI. AbbVie agreed to buy Apogee for ~$10.9B cash ($135.11/share). Oil eased as traders expected US-Iran supply disruptions to lessen; core PCE and Micron earnings are key this week.

proactiveinvestors.com7 min